The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial introduction generated massive gains, the lapse of its patent opened the floodgates to cheaper versions, https://siambookmark.com/story21667987/sildenafil-and-pharma-a-risky-opportunity